Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.70%958M | -1.43%1.03B | -0.26%773M | 4.52%3.47B | 6.10%730M | -3.58%915M | 7.92%1.05B | 9.15%775M | 8.29%3.32B | 3.46%688M |
| Operating revenue | 4.70%958M | -1.43%1.03B | -0.26%773M | 4.52%3.47B | 6.10%730M | -3.58%915M | 7.92%1.05B | 9.15%775M | 8.29%3.32B | 3.46%688M |
| Cost of revenue | 5.91%770M | 0.61%828M | 0.33%605M | 4.33%2.75B | 7.44%592M | -0.95%727M | 6.61%823M | 5.05%603M | 3.54%2.63B | -0.36%551M |
| Gross profit | 0.00%188M | -8.85%206M | -2.33%168M | 5.23%724M | 0.73%138M | -12.56%188M | 13.00%226M | 26.47%172M | 31.30%688M | 22.32%137M |
| Operating expense | -8.62%53M | -12.07%51M | 10.42%53M | 16.93%221M | 18.75%57M | 18.37%58M | 13.73%58M | 17.07%48M | 14.55%189M | -5.88%48M |
| Selling and administrative expenses | -6.00%47M | 0.00%52M | 6.98%46M | 15.06%191M | 12.20%46M | 13.64%50M | 18.18%52M | 16.22%43M | 16.90%166M | 5.13%41M |
| Depreciation amortization depletion | 33.33%4M | -25.00%3M | 0.00%4M | 0.00%15M | 33.33%4M | -25.00%3M | 0.00%4M | 0.00%4M | 0.00%15M | -40.00%3M |
| -Depreciation and amortization | 33.33%4M | -25.00%3M | 0.00%4M | 0.00%15M | 33.33%4M | -25.00%3M | 0.00%4M | 0.00%4M | 0.00%15M | -40.00%3M |
| Other operating expenses | -60.00%2M | -300.00%-4M | 200.00%3M | 87.50%15M | 75.00%7M | 400.00%5M | -33.33%2M | --1M | 0.00%8M | -42.86%4M |
| Operating profit | 3.85%135M | -7.74%155M | -7.26%115M | 0.80%503M | -8.99%81M | -21.69%130M | 12.75%168M | 30.53%124M | 39.00%499M | 45.90%89M |
| Net non-operating interest income (expenses) | 21.74%-18M | 30.00%-14M | 9.09%-20M | -29.41%-88M | -9.52%-23M | -35.29%-23M | -25.00%-20M | -57.14%-22M | -106.06%-68M | -90.91%-21M |
| Non-operating interest expense | -21.74%18M | -30.00%14M | -9.09%20M | 29.41%88M | 9.52%23M | 35.29%23M | 25.00%20M | 57.14%22M | 106.06%68M | 90.91%21M |
| Other net income (expenses) | 28M | |||||||||
| Special income (charges) | --0 | --0 | --28M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---- | ---28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 9.35%117M | -4.73%141M | 20.59%123M | -3.71%415M | -14.71%58M | -28.19%107M | 11.28%148M | 25.93%102M | 32.21%431M | 36.00%68M |
| Income tax | 7.41%29M | -7.89%35M | 20.00%30M | -8.57%96M | -50.00%6M | -30.77%27M | 15.15%38M | 19.05%25M | 23.53%105M | -14.29%12M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 10.00%88M | -3.64%106M | 20.78%93M | -2.15%319M | -7.14%52M | -27.27%80M | 10.00%110M | 28.33%77M | 35.27%326M | 55.56%56M |
| Net income continuous operations | 10.00%88M | -3.64%106M | 20.78%93M | -2.15%319M | -7.14%52M | -27.27%80M | 10.00%110M | 28.33%77M | 35.27%326M | 55.56%56M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 10.00%88M | -3.64%106M | 20.78%93M | -2.15%319M | -7.14%52M | -27.27%80M | 10.00%110M | 28.33%77M | 35.27%326M | 55.56%56M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 10.00%88M | -3.64%106M | 20.78%93M | -2.15%319M | -7.14%52M | -27.27%80M | 10.00%110M | 28.33%77M | 35.27%326M | 55.56%56M |
| Diluted earnings per share | 11.97%1.59 | -1.55%1.91 | 22.79%1.67 | 0.71%5.66 | -6.06%0.93 | -25.65%1.42 | 12.79%1.94 | 32.04%1.36 | 43.00%5.62 | 57.14%0.99 |
| Basic earnings per share | 11.97%1.59 | -1.55%1.91 | 22.79%1.67 | 0.71%5.66 | -6.06%0.93 | -25.65%1.42 | 12.79%1.94 | 32.04%1.36 | 43.00%5.62 | 57.14%0.99 |
| Dividend per share | 10.71%0.31 | 10.71%0.31 | 10.71%0.31 | 21.74%1.12 | 21.74%0.28 | 21.74%0.28 | 21.74%0.28 | 21.74%0.28 | 15.00%0.92 | 15.00%0.23 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.